Q BioMed strikes an early-stage autism deal with Asdera
Medcity News,
Two New York City biopharma companies, Q BioMed and Asdera, have signed a licensing deal built around a therapeutic…
Two New York City biopharma companies, Q BioMed and Asdera, have signed a licensing deal built around a therapeutic…
/PRNewswire/ -- Q BioMed Inc. (OTCQB: QBIO) and ASDERA LLC today announce a licensing agreement that provides Q Biomed with the…
SOURCE Q BioMed Inc New Treatment in Development Looks to Treat Rare Condition that Robs Approximately 20,000 US Children per…
SOURCE Q BioMed Inc New Treatment in Development Looks to Treat Rare Condition that Robs Approximately 20,000 US Children per…